Suchergebnisse
Suchergebnisse:
Vor einem Tag · Register your place here (and take advantage of group discounts of up to 20% when sending your team of three or more!): https://ter.li/c487li. 3rd mRNA Process Development & Manufacturing Summit ...
Vor 2 Tagen · Esteve to acquire Perrigo’s HRA pharma rare diseases business. 29-04-2024. Family-controlled Spanish pharma company Esteve has signed a binding offer with USA-based Perrigo Company to acquire the latter’s HRA Pharma Rare Diseases, a specialist in rare and ultra-rare diseases.
Vor einem Tag · Accelerating Digital Technology for the COVID-19 Vaccine Rollout. March 2022. Pfizer and BioNTech’s embrace of novel mRNA science played a pivotal role in achieving a record-breaking COVID-19 vaccine rollout.
Vor 3 Tagen · PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer (PFE.N) and AstraZeneca (AZN.L) announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start ...
Vor 3 Tagen · The Pfizer R&D Rotational Program is a 2-year commitment to increase minority representation at Pfizer, designed to immerse early career colleagues into the pharmaceutical R&D business through three to four unique 6- to 8-month job rotations in diverse disciplines.
Vor einem Tag · MannKind is investigating an inhaled version of the drug in the rare NTM lung disease and plans to start a registrational trial later this year, according to the company's Monday release....
Vor 3 Tagen · Cellular immunity is critical for the regulation of viral diseases, including coronavirus disease 2019 (COVID-19), and is generally considered immature in childhood. However, the details of cellular immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among children are unclear. We assessed cellular immunity in eight children post-vaccination against SARS-CoV ...
